MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas

Cell Proliferation

Volumn 30, Issue 1, 1997, Pages 37-47

  Mochen, C ^a   Giardini, R ^a   Costa, A ^a   Silvestrini, R ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL KINETICS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME;

EID: 0030761395     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1997.tb00914.x     Document Type: Article

References (32)

1. ARMITAGE JO. (1993) Treatment of non-Hodgkin's lymphoma. N. Engl. J. Med. 328, 1023.
2. BRONS PPT, RAEMAEKERS JMM, BOGMAN MJJT et al. (1992) Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood 80, 2336.
3. CARBONE PP, KAPLAN HS, MUSSHOFF K, SMITHERS DW, TUBIANA M. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 31, 1860.
4. CATTORETTI G, BECKER MHG, KEY G et al. (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol. 168, 357.
5. COSTA A, BONADONNA G, VILLA E, VALAGUSSA P, SILVESTRINI R. (1981) Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J. Natl. Cancer Inst. 66, 1.
6. 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma. Br. J. Cancer 66, 680.
7. CZADER M, PORWIT A, TANI E, ÖST Å, MAZUR J, AUER G. (1995) DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Mod. Pathol. 8, 51.
8. DUQUE RE, ANDREEFF M, BRAYLAN RC, DIAMOND LW, PEIPER SC. (1993) Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 14, 492.
9. GERDES J, DALLENBACH F, LENNERT K. (1984) Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol. Oncol. 2, 365.
10. GERDES J, STEIN H, PILERI S et al. (1987) Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet 2, 448.
11. GROGAN TM, LIPPMAN SM, SPIER CM et al. (1988) Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 71, 1157.
12. HALL PA, RICHARDS MA, GREGORY WM, D'ARDENNE AJ, LISTER TA, STANSFELD AG. (1988) The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J. Pathol. 154, 223.
13. HARRIS NL, JAFFE ES, STEIN H et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84, 1361.
14. HIDDEMANN W, UNTERHALT M. (1994) Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas. Blood Rev. 8, 225.
15. JOENSUU H, RISTAMÄKI, SÖDERSTRÖM K, JALKANEN S. (1994) Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma. J. Clin. Oncol. 12, 2167.
16. KAWAUCHI K, SATO Y, FURUYA T, WATANABE S. (1989) Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki-67 in malignant lymphomas. Hematol. Oncol. 7, 257.
17. KERNS B-JM, JORDAN PA, FAERMAN LL, BERCHUCK A, BAST RC, LAYFIELD LJ. (1994) Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. Am. J. Clin. Pathol. 101, 192.
18. KEY G, BECKER MHG, DUCHROW M, SCHLUTER C, GERDES J. (1992) New Ki-67 equivalent murine monoclonal antibodies (MIB1-3) prepared against recombinant parts of the Ki-67 antigen. Anal. Cell Pathol. 4, 181.
19. LEONCINI L, DEL VECCHIO MT, MEGHA T et al. (1993) Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol. 142, 755.
20. MEDEIROS LJ, PICKER LJ, GELB AB et al. (1989) Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomas. J. Clin. Oncol. 7, 1009.
21. MILLER TP, GROGAN TM, DAHLBERG S et al. (1994) Prognostic significance of the Ki-67-associated proliferative antigen in high-grade non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood 83, 1460.
22. NAKAMURA S, AKAZAWA K, YAO T, TSUNEYOSHI M. (1995) Primary gastric lymphoma. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 76, 1313.
23. PICH A, PONTI R, VALENTE G et al. (1994) MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J. Clin. Pathol. 47, 18.
24. SABATTINI E, GERDES J, GHERLINZONI F et al. (1993) Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J. Pathol. 169, 397.
25. SIGURDSSON H, BALDETORP B, BORG Å et al. (1990) Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorization of cut-off levels. Br. J. Cancer 62, 786.
26. SILVESTRINI R, COSTA A, BORACCHI P, GIARDINI R, RILKE F. (1993) Cell proliferation as a long-term prognostic factor in diffuse large-cell lymphomas. Int. J. Cancer 54, 231.
27. SILVESTRINI R, COSTA A, GIARDINI R et al. (1989) Prognostic implications of cell kinetics, histopathology and pathologic stage in non-Hodgkin's lymphomas. Hematol. Oncol. 7, 411.
28. SKALOVA A, LEHTONEN H, VON BOGUSLAWSKY K, LEIVO I. (1994) Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum. Pathol. 25, 929.
29. SLYMEN DJ, MILLER TP, LIPPMAN SM et al. (1990) Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma. J. Clin. Oncol. 8, 986.
30. URBA WJ, DUFFEY PL, LONGO DL. (1990) Treatment of patients with high-grade lymphomas: an overview. J. Natl. Cancer Inst. Mon̈ogr. 10, 29.
31. 3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomas. Hematol. Oncol. 6, 21.
32. WITZIG TE, HABERMANN TM, KURTIN PJ, SCHROEDER G, STENSON MJ, GREIPP PR. (1995) S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma. Cancer 76, 1059.